Screening for Cervical Cancer Precursors With p16/Ki-67 Dual-Stained Cytology: Results of the PALMS Study

CINtec PLUS Immunocytochemistry as a Tool for the Cytologic Diagnosis of Glandular Lesions of the Cervix Uteri

(2012) Alberto Ravarino et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer

(2012) Debbie Saslow et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

p16INK4aimmunocytochemistry versus human papillomavirus testing for triage of women with minor cytologic abnormalities

(2012) Jolien Roelens et al.   CANCER CYTOPATHOLOGY

Evaluation of p16INK4a/Ki-67 dual stain in comparison with an mRNA human papillomavirus test on liquid-based cytology samples with low-grade squamous intraepithelial lesion

(2012) Marianne Waldstrøm et al.   CANCER CYTOPATHOLOGY

Performance of p16/Ki-67 Immunostaining to Detect Cervical Cancer Precursors in a Colposcopy Referral Population

(2012) N. Wentzensen et al.   CLINICAL CANCER RESEARCH

Triage of HPV-positive women in cervical cancer screening

(2012) Nicolas Wentzensen   LANCET ONCOLOGY

Risk of high-grade cervical intraepithelial neoplasia during follow-up in HPV-positive women according to baseline p16-INK4A results: a prospective analysis of a nested substudy of the NTCC randomised controlled trial

(2012) Francesca Carozzi et al.   LANCET ONCOLOGY

Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer

(2012) Marc Arbyn et al.   VACCINE

Immunocytochemical colocalization of p16INK4a and Ki-67 predicts CIN2/3 and AIS/adenocarcinoma

(2011) Meenakshi Singh et al.   CANCER CYTOPATHOLOGY

p16/ki-67 dual-stain cytology in the triage of ASCUS and LSIL Papanicolaou cytology

(2011) Dietmar Schmidt et al.   CANCER CYTOPATHOLOGY

Triaging Pap cytology negative, HPV positive cervical cancer screening results with p16/Ki-67 Dual-stained cytology

(2011) K. Ulrich Petry et al.   GYNECOLOGIC ONCOLOGY

Human Papillomavirus Testing in the Prevention of Cervical Cancer

(2011) Mark Schiffman et al.   JNCI-Journal of the National Cancer Institute

Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study

(2011) Philip E Castle et al.   LANCET ONCOLOGY

Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial

(2010) Guglielmo Ronco et al.   LANCET ONCOLOGY

Human Papillomavirus mRNA and p16 Detection as Biomarkers for the Improved Diagnosis of Cervical Neoplasia

(2008) K. Cuschieri et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Rapid Clearance of Human Papillomavirus and Implications for Clinical Focus on Persistent Infections

(2008) A. C. Rodriguez et al.   JNCI-Journal of the National Cancer Institute

Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trial

(2008) Francesca Carozzi et al.   LANCET ONCOLOGY